- Home
- ELAB vs PBM Comparison
ELAB vs PBM Comparison
Compare ELAB & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELAB
- PBM
- Stock Information
- Founded
- ELAB 2020
- PBM 1994
- Country
- ELAB United States
- PBM Canada
- Employees
- ELAB N/A
- PBM N/A
- Industry
- ELAB
- PBM
- Sector
- ELAB
- PBM
- Exchange
- ELAB Nasdaq
- PBM NYSE
- Market Cap
- ELAB 6.6M
- PBM 5.3M
- IPO Year
- ELAB 2023
- PBM N/A
- Fundamental
- Price
- ELAB $2.47
- PBM $5.20
- Analyst Decision
- ELAB
- PBM
- Analyst Count
- ELAB 0
- PBM 0
- Target Price
- ELAB N/A
- PBM N/A
- AVG Volume (30 Days)
- ELAB 711.3K
- PBM 89.7K
- Earning Date
- ELAB 05-23-2025
- PBM 07-07-2025
- Dividend Yield
- ELAB N/A
- PBM N/A
- EPS Growth
- ELAB N/A
- PBM N/A
- EPS
- ELAB N/A
- PBM N/A
- Revenue
- ELAB N/A
- PBM N/A
- Revenue This Year
- ELAB N/A
- PBM N/A
- Revenue Next Year
- ELAB N/A
- PBM N/A
- P/E Ratio
- ELAB N/A
- PBM N/A
- Revenue Growth
- ELAB N/A
- PBM N/A
- 52 Week Low
- ELAB $2.14
- PBM $0.41
- 52 Week High
- ELAB $980.00
- PBM $824.90
- Technical
- Relative Strength Index (RSI)
- ELAB 37.57
- PBM 60.63
- Support Level
- ELAB $2.37
- PBM $3.41
- Resistance Level
- ELAB $2.55
- PBM $4.80
- Average True Range (ATR)
- ELAB 0.22
- PBM 0.77
- MACD
- ELAB 0.15
- PBM 0.19
- Stochastic Oscillator
- ELAB 31.13
- PBM 86.19
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.